DIETATRY APPROACHES AND PREVENTION OF THE ADVANCEMENT OF SYMPTOMS OF ALZHEIMER’S DISEASE
DOI:
https://doi.org/10.47820/recima21.v4i12.4477Keywords:
Omega-3, Alzheimer's Disease, docosahexaenoic acid (DHA), neuroprotection, dietary supplementationAbstract
The present study aims to analyze the scientific evidence related to the use of omega-3 in the treatment of Alzheimer's Disease (AD). Methodology - To carry out this study, a descriptive and qualitative bibliographic research was conducted. Original articles published in journals indexed in databases in Portuguese and English related to omega-3 supplementation in the treatment of AD were selected. Narrative, descriptive, integrative and systematic review articles with meta-analysis, as well as those not aligned with the theme, were excluded. Results - Critical analysis of the selected studies demonstrated that omega-3 supplementation may be beneficial in reducing the risk of developing AD and slowing the progression of symptoms in patients already diagnosed. The neuroprotective action of DHA, in particular, is associated with the maintenance of brain lipid metabolism, the regulation of neurotransmission processes, and the reduction of oxidative stress. Conclusion - Based on the scientific evidence analyzed, the use of omega-3, especially DHA, emerges as a possible promising therapeutic approach in the management of Alzheimer's Disease. Omega-3 supplementation may play a significant role in the prevention and treatment of this neurodegenerative condition. However, further clinical studies are needed to consolidate these findings and establish clear guidelines for their use in clinical practice.
Downloads
References
Yiannopoulou KG, Papageorgiou SG. Current and Future Treatments in Alzheimer Disease: An Update. J Cent Nerv Syst Dis. 29 jan 2020;12:117957352090739.
Sereniki A, Vital MABF. A doença de Alzheimer: aspectos fisiopatológicos e farmacológicos. Revista de Psiquiatria do Rio Grande do Sul. 2008;30(1 suppl).
McNamara RK, Asch RH, Lindquist DM, Krikorian R. Role of polyunsaturated fatty acids in human brain structure and function across the lifespan: An update on neuroimaging findings. Prostaglandins Leukot Essent Fatty Acids. set 2018;136:23–34.
Youdim KA, Martin A, Joseph JA. Essential fatty acids and the brain: possible health implications. International Journal of Developmental Neuroscience. 15 jul 2000;18(4–5):383–99.
Costa PJ, Silva MM da, Guedes JP. Os efeitos do uso do ômega 3 no tratamento de pacientes com Alzheimer. Research, Society and Development. 18 nov 2021;10(15):e239101522654.
Antônio C. Gil. Como Elaborar Projetos de Pesquisa. São Paulo: Editora Atlas; 2017. p. 1–128.
Alzheimer’s disease facts and figures. Alzheimer’s & Dementia. 23 mar 2021;17(3):327–406.
Reisberg B, Shulman MB, Torossian C, Leng L, Zhu W. Outcome over seven years of healthy adults with and without subjective cognitive impairment. Alzheimer’s & Dementia. Jan 2010;6(1):11–24.
Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: A systematic review and metaanalysis. Alzheimer’s & Dementia. jan 2013;9(1):63.
Ojopi EPB, Bertoncini AB, Dias Neto E. Apolipoproteína E e a doença de Alzheimer. Archives of Clinical Psychiatry (São Paulo) [Internet]. 2004;31(1):26–33. Disponível em: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S010160832004000100005&lng=pt&nrm=iso&tlng=en
Bherer L, Erickson KI, Liu-Ambrose T. A Review of the Effects of Physical Activity and Exercise on Cognitive and Brain Functions in Older Adults. J Aging Res. 2013;2013:1–8.
Vasquez FJ de A. Explorando o papel dos RNAs longos não codificadores na doença de Alzheimer. [Ribeirão Preto]: Universidade de São Paulo; 2022.
Calder PC. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. abr 2015;1851(4):469–84.
Kris-Etherton PM, Harris WS, Appel LJ. Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease. Circulation. 19 nov 2002;106(21):2747–57.
Martin CA, Almeida VV de, Ruiz MR, Visentainer JEL, Matshushita M, Souza NE de, et al. Ácidos graxos poliinsaturados ômega-3 e ômega-6: importância e ocorrência em alimentos. Revista de Nutrição. dez 2006;19(6):761–70.
Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine & Pharmacotherapy. out 2002;56(8):365–79.
Ministério da Saúde. Biblioteca Virtual em Saúde do Ministério da Saúde [Internet]. 2014. 1–158 p. Disponível em: www.saude.gov.br/bvs
Bueno Zanardo P, Cláudia Bernardes Spexoto M, Fernandes Coutinho V, Bueno Zanardo -Rua Professor Mendes Pimentel P, Santa Adélia J, Paulo S. Benefícios do Ômega-3 (-3) na doença de Alzheimer Benefits of omega-3 (-3) in Alzheimer’s disease Endereço para Correspondência. Revisão Neurociências Revista Inova Saúde, Criciúma. 2014;3.
Ahmed RM, Irish M, Kam J, van Keizerswaard J, Bartley L, Samaras K, et al. Quantifying the Eating Abnormalities in Frontotemporal Dementia. JAMA Neurol. 1 dez 2014;71(12):1540.
Downloads
Published
License
Copyright (c) 2023 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
This work is licensed under a Creative Commons Attribution 4.0 International License.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.
